Literature DB >> 12007717

Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease.

Kyoko Kaminishi1, Yoshinao Soma, Yoko Kawa, Masako Mizoguchi.   

Abstract

Recent studies have shown increased T-helper (Th) 2 cytokine expression and decreased IFN-gamma expression in peripheral blood from patients with atopic dermatitis (AD). In the present study, we examined the cytokine expression in peripheral blood mononuclear cells in patients with AD and tested how the cytokine profile correlated with the patients' age, severity and laboratory findings. Peripheral blood mononuclear cells obtained from 20 patients with AD were stimulated with phorbol 12-myristate 13-acetate and ionomycin, and were examined for the frequencies of CD4+ cells expressing IL-4, IL-13 and IFN-gamma at the single cell level using intracellular cytokine staining and flow cytometry. There was a significant positive correlation between IL-4 and IL-13 expression in CD4+ cells. Expression levels of both IL-4 and IL-13 in CD4+ cells were significantly correlated with peripheral blood eosinophilia. These findings suggest that CD4+ cells producing IL-4 and IL-13 play important roles in the pathogenesis of AD. IFN-gamma expression did not correlate with either IL-4 or IL-13 expression, or with blood eosinophilia. We also measured serum levels of IL-13 in 144 patients with AD using enzyme-linked immunosorbent assay, and found 16 patients with detectable levels of serum IL-13. IL-13+ patients had significantly higher serum IgE levels than IL-13- patients, suggesting a direct association between serum levels of IL-13 and IgE. It was also shown that the IL-13+ group was significantly younger in age than the IL-13- group, although the implication of this finding is not clear at present. The sum of these findings suggested that the predominance of Th2 cells and the consequent overexpression of IL-4 and IL-13 in peripheral blood may be deeply involved in the pathogenetic process of AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007717     DOI: 10.1016/s0923-1811(01)00174-8

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  12 in total

1.  Impact of T-cell receptor Vbeta haplotypes on the development of dermatitis in DS-Nh mice: synergistic production of interleukin-13 caused by staphylococcal enterotoxin C and peptide glycans from Staphylococcus aureus.

Authors:  Takeshi Yoshioka; Kinichi Imura; Ichiro Hikita; Tsutomu Hirasawa; Tsuneaki Sakata; Takaji Matsutani; Tatsuya Horikawa; Akinori Arimura
Journal:  Immunology       Date:  2007-02-20       Impact factor: 7.397

Review 2.  The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Authors:  Patrick M Brunner; Emma Guttman-Yassky; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2017-04       Impact factor: 10.793

3.  Improvement of atopic dermatitis and alopecia universalis with dupilumab.

Authors:  Lama Alotaibi; Abdulrahman Alfawzan; Raghad Alharthi; Afaf Al Sheikh
Journal:  Dermatol Reports       Date:  2021-12-28

4.  Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets.

Authors:  Tali Czarnowicki; Hitokazu Esaki; Juana Gonzalez; Dana Malajian; Avner Shemer; Shinji Noda; Sreya Talasila; Adam Berry; Jayla Gray; Lauren Becker; Yeriel Estrada; Hui Xu; Xiuzhong Zheng; Mayte Suárez-Fariñas; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-08-01       Impact factor: 10.793

5.  Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood.

Authors:  Tali Czarnowicki; Helen He; Talia Canter; Joseph Han; Rachel Lefferdink; Taylor Erickson; Stephanie Rangel; Naoya Kameyama; Hyun Je Kim; Ana B Pavel; Yeriel Estrada; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2019-10-15       Impact factor: 10.793

6.  Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rγ(null) mice engrafted with human peripheral blood mononuclear cells.

Authors:  Thomas Nolte; Maryam Zadeh-Khorasani; Orkhan Safarov; Franziska Rueff; Rita Varga; Nadja Herbach; Rüdiger Wanke; Andreas Wollenberg; Thomas Mueller; Roswitha Gropp; Eckhard Wolf; Matthias Siebeck
Journal:  Dis Model Mech       Date:  2012-07-19       Impact factor: 5.758

7.  NOD-scid IL2R γnull mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways.

Authors:  Maryam Zadeh-Khorasani; Thomas Nolte; Thomas D Mueller; Markos Pechlivanis; Franziska Rueff; Andreas Wollenberg; Gert Fricker; Eckhard Wolf; Matthias Siebeck; Roswitha Gropp
Journal:  J Transl Med       Date:  2013-01-07       Impact factor: 5.531

Review 8.  Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.

Authors:  Angelo Massimiliano D'Erme; Marco Romanelli; Andrea Chiricozzi
Journal:  Drug Des Devel Ther       Date:  2017-05-15       Impact factor: 4.162

Review 9.  New era of biologic therapeutics in atopic dermatitis.

Authors:  Emma Guttman-Yassky; Nikhil Dhingra; Donald Y M Leung
Journal:  Expert Opin Biol Ther       Date:  2013-01-16       Impact factor: 4.388

10.  Allergic phenotypes in adult patients with atopic dermatitis, determined with the ISAC test (ImmunoCAP ISAC).

Authors:  Milena Wojciechowska; Magdalena Żbikowska-Gotz; Luiza Marek-Józefowicz; Michał Przybyszewski; Jacek Gocki; Zbigniew Bartuzi
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.